Key benchmark indices logged modest losses on selling pressure in index
Al Jazeera Media Network would partner with Bloomberg Media Distribution as part of a content license agreement to expand its global business news coverage.
Dr Reddy’s Laboratories dropped 5.5%. Dr Reddy’s Laboratories announced that the audit of its formulations manufacturing plant – 3 at Bachupally, Hyderabad by the US Food and Drug Administration (USFDA) completed on 8 February 2019. The company has been issued a Form 483 with 11 observations
Shares of Aurobindo Pharma gained 1% after the company completed the acquisition of Apotex’s commercial operations and certain supporting infrastructure in five European countries.
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Sevelamer Hydrochloride Tablets, 400mg and 800mg, a generic version of Renagel tablets, 400mg and 800mg, of Genzyme Corporation.
REC announced that its board approved the proposal for incorporation of five project specific special purpose vehicles (SPVs), as wholly owned subsidiary companies of REC Transmission Projects Company for construction of projects.
Asian shares barely moved on Monday as investors were unable to shake worries about global growth, U.S. politics and the Sino-U.S. trade war, keeping the safe haven dollar near a six-week top against major currencies.
China’s blue-chip index surged 1.6 percent while Shanghai’s SSE Composite climbed 1.2%
Australia stocks were lower after the close on Monday, as losses in the Financials, Healthcare and Telecoms Services sectors led shares lower. The S&P/ASX 200 fell 0.18%.
(Click to submit your details) Just one step to get best trading tips and Recommendation